Viewing Study NCT03005002


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-03-06 @ 6:39 PM
Study NCT ID: NCT03005002
Status: COMPLETED
Last Update Posted: 2019-12-26
First Post: 2016-12-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver
Sponsor: City of Hope Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 16423
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View